I am with you that it seems a bit early for this to be Brilacidin, especially since we haven't had any human trial results to positively affirm it will work as shown it should in all tests to date.
But then again, could there have been unannounced major work being done w/ patients over the last few weeks? Many here have questioned the speed of advancement seemingly pretty slow for such promising early test results.
If it is not B, I believe that when our trial gets finished (and all testing on B gets completed) that it will be hard for any competitor to prove as effective and safe as Brilacidin should prove. Also hope B has a price advantage as well.
Exciting times.
News 
Market Data 
Discover 
